• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Hoth Therapeutics(HOTH.US)

Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov13
Hoth Therapeutics released FY2025 9 Months Earnings on November 12 (EST), with actual revenue of USD 0 and EPS of USD -0.7377
04:00
Hoth Therapeutics released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.2977 (forecast USD -0.07)
04:00
Oct21
Hoth Therapeutics, Inc.'s drug HT-KIT obtains FDA Orphan Drug Designation
12:23
Oct17
Hoth Therapeutics to Release Operations and Progress in Drug Development
20:51
Aug13
Hoth Therapeutics released FY2025 Semi-Annual earnings on August 12 (EST), actual revenue USD 0, actual EPS USD -0.4379
03:00
Hoth Therapeutics released FY2025 Q2 earnings on August 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.1699 (forecast USD -0.14)
03:00

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -4.106 M, EPS -0.2977

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -2.199 M, EPS -0.1668

May12
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -3.476 M, EPS -0.273

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INBS
11.615
+183.29%
+7.500
ANGH
3.870
+66.81%
+1.550
ESHA
22.456
+56.16%
+8.076
SIDU
4.050
+51.67%
+1.395
ESHAR
0.2500
+47.06%
+0.080
NCL
0.2773
+42.94%
+0.083
RDACR
0.2493
+31.21%
+0.059
VNDA
8.935
+27.10%
+1.901
ORIS
1.530
+25.41%
+0.310
ULY
3.420
+23.92%
+0.660
View More